68
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease

, , , &
Pages 1915-1919 | Published online: 09 Jul 2019

References

  • Clark CM, Ewbank D, Lerner A, et al. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer’s disease enrolled in the CERAD study. Neurology. 1997;49:70–75. doi:10.1212/wnl.49.1.709222172
  • Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, et al. Motor signs during the course of alzheimer disease. Neurology. 2004;63:975–982. doi:10.1212/01.WNL.0000138440.39918.0C15452286
  • Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Parkinsonianlike signs and risk of incident alzheimer disease in older persons. Arch Neurol. 2003;60:539–544. doi:10.1001/archneur.60.4.53912707067
  • Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA. Motor dysfunction in mild cognitive impairment and the risk of incident alzheimer disease. Arch Neurol. 2006;63:1763–1769. doi:10.1001/archneur.63.12.176317172617
  • Stern Y, Albert M, Brandt J, et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in alzheimer’s disease: prospective analyses from the predictors study. Neurology. 1994;44:2300–2307. doi:10.1212/wnl.44.9.17157991116
  • Hulette C, Mirra S, Wilkinson W, Heyman A, Fillenbaum G, Clark C. The consortium to establish a registry for alzheimer’s disease (CERAD) part IX. A prospective cliniconeuropathologic study of Parkinson’s features in alzheimer’s disease. Neurology. 1995;45:1991–1995. doi:10.1212/WNL.45.11.19917501147
  • Liu WK, Le TV, Adamson J, et al. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann Neurol. 2001;50:494–502. doi:10.1002/ana.115911601500
  • Scarmeas N, Brandt J, Albert M, et al. Delusions and hallucinations are associated with worse outcome in alzheimer disease. Arch Neurol. 2005;62:1601–1608. doi:10.1001/archneur.62.10.160116216946
  • Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of alzheimer’s disease in late onset families. Science. 1993;261:921–923. doi:10.1126/science.83464438346443
  • Sperling R, Mormino E, Johnson K. The evolution of preclinical alzheimer’s disease: implications for prevention trials. Neuron. 2014;84:608–622. doi:10.1016/j.neuron.2014.10.03825442939
  • Ellis RJ, Caligiuri M, Galasko D, Thal LJ. Extrapyramidal motor signs in clinically diagnosed alzheimer disease. Alzheimer Dis Assoc Disord. 1996;10:103–114. doi:10.1097/00002093-199601020-000088727172
  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on alzheimer’s disease. Neurology. 1984;34:939–944. doi:10.1212/WNL.34.7.9396610841
  • Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106–118. doi:10.1038/nrneurol.2012.26323296339
  • Attems J, Quass M, Jellinger KA. Tau and alpha-synuclein brainstem pathology in alzheimer disease: relation with extrapyramidal signs. Acta Neuropathol. 2007;113:53–62. doi:10.1007/s00401-006-0146-917031655
  • Liu Y, Stern Y, Chun MR, Jacobs DM, Yau P, Goldman JE. Pathological correlates of extrapyramidal signs in Alzheimer’s disease. Ann Neurol. 1997;41:368–374. doi:10.1002/(ISSN)1531-82499066358
  • Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the lewy body variant of alzheimer’s disease. Neurology. 1994;44:1950–1951. doi:10.1212/wnl.44.9.17157936253
  • Kobayashi S, Tateno M, Park TW, et al. Apolipoprotein E4 frequencies in a Japanese population with Alzheimer’s disease and dementia with lewy bodies. PLoS One. 2011;6:e18569. doi:10.1371/journal.pone.001856921552550
  • Iqbal K, Flory M, Soininen H. Clinical symptoms and symptom signatures of alzheimer’s disease subgroups. J Alzheimers Dis. 2013;37:475–481. doi:10.3233/JAD-13021224002184
  • Kaur B, Harvey DJ, DeCarli CS, Zhang L, Sabbagh MN, Olichney JM. Extrapyramidal signs by dementia severity in alzheimer disease and dementia with lewy bodies. Alzheimer Dis Assoc Disord. 2013;27:226–232. doi:10.1097/WAD.0b013e31826f040d23023095
  • Monsell SE, Besser LM, Heller KB, Checkoway H, Litvan I, Kukull WA. Clinical and pathologic presentation in parkinson’s disease by apolipoprotein e4 allele status. Parkinsonism Relat Disord. 2014;20:503–507. doi:10.1016/j.parkreldis.2014.02.00124582705
  • Yang Y, Fuh J, Mok VCT. Vascular contribution to cognition in stroke and alzheimer’s disease. Brain Sci Adv. 2018;4:39–48. doi:10.26599/BSA.2018.9050001